193
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Assessing mitochondrial DNA nucleotide changes in spontaneous optic neuropathies

&
Pages 163-172 | Received 06 May 2010, Accepted 01 Aug 2010, Published online: 11 Nov 2010

REFERENCES

  • Leber T. Ueber hereditaere und congenital angelegte sehnervenleiden. Graefes Arch Clin Exp Ophthalmol 1871;17:249–291.
  • Brown MD. The enigmatic relationship between mitochondrial dysfunction and Leber’s hereditary optic neuropathy. J. Neurol. Sci. 1999;165:1–5.
  • Chalmers RM, Schapira AH. Clinical, biochemical and molecular genetic features of Leber’s hereditary optic neuropathy. Biochim Biophys Acta 1999;1410:147–158.
  • Wallace DC, Brown MD, Lott MT. Mitochondrial DNA variation in human evolution and disease. Gene 1999;238:211–230.
  • Guy J, Qi X, Pallotti F, et al. Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy. Ann Neurol 2002;52:534–542.
  • Kerrison JB, Newman NJ. Clinical spectrum of Leber’s hereditary optic neuropathy. Clin Neurosci 1997;4:295–301.
  • Huoponen K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics 2001;3:119–125.
  • Stone EM, Newman NJ, Miller NR, Johns DR, Lott MT, Wallace DC. Visual recovery in patients with Leber’s hereditary optic neuropathy and the 11778 mutation. J Clin Neuroophthalmol 1992;12:10–14.
  • Erickson RP. Leber’s optic atrophy, a possible example of maternal inheritance. Am J Hum Genet 1972;24:348–349.
  • Wallace D, Singh G, Lott M, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 1988;242:1427–1430.
  • Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber’s hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 1991;111:750–762.
  • Smith KH, Johns DR, Heher KL, Miller NR. Heteroplasmy in Leber’s hereditary optic neuropathy. Arch Ophthalmol 1993;111:1486–1490.
  • Huoponen K, Vilkki J, Aula P, Nikoskelainen EK, Savontaus ML. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet 1991;48:1147–1153.
  • Howell N, Bindoff LA, McCullough DA, et al. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet 1991;49:939–950.
  • Mackey D, Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet 1992;51:1218–1228.
  • Johns DR, Neufeld MJ, Park RD. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun 1992;187:1551–1557.
  • Mackey DA, Oostra RJ, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 1996;59:481–485.
  • Brown MD, Sun F, Wallace DC. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 1997;60:381–387.
  • Nakamura M. Genetic analysis of Japanese pedigrees with Leber’s hereditary optic neuropathy. Kobe J Med Sci 1993;39:171–182.
  • Kim JY, Hwang JM, Chang BL, Park SS. Spectrum of the mitochondrial DNA mutations of Leber’s hereditary optic neuropathy in Koreans. J Neurol 2003;250:278–281.
  • Newman NJ. Leber’s hereditary optic neuropathy. New genetic considerations. Arch Neurol 1993;50:540–548.
  • Huoponen K, Lamminen T, Juvonen V, Aula P, Nikoskelainen E, Savontaus ML. The spectrum of mitochondrial DNA mutations in families with Leber hereditary optic neuroretinopathy. Hum Genet 1993;92:379–384.
  • Brown MD, Torroni A, Reckord CL, Wallace DC. Phylogenetic analysis of Leber’s hereditary optic neuropathy mitochondrial DNA’s indicates multiple independent occurrences of the common mutations. Hum Mutat 1995;6:311–325.
  • Howell N, Kubacka I, Halvorson S, Howell B, McCullough DA, Mackey D. Phylogenetic analysis of the mitochondrial genomes from Leber hereditary optic neuropathy pedigrees. Genetics 1995;140:285–302.
  • Torroni A, Huoponen K, Francalacci P, et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 1996;144:1835–1850.
  • Gerbitz KD, Paprotta A, Obermaier-Kusser B, Rietschel M, Zerres K. No genetic differences between affected and unaffected members of a German family with Leber’s hereditary optic neuropathy (LHON) with respect to ten mtDNA point mutations associated with LHON. FEBS Lett 1992;314:251–255.
  • Wallace DC, Lott MT, Shoffner JM, Brown MD. Diseases resulting from mitochondrial DNA point mutations. J Inherit Metab Dis 1992;15:472–479.
  • Brown MD, Allen JC, Van Stavern GP, Newman NJ, Wallace DC. Clinical, genetic, and biochemical characterization of a Leber hereditary optic neuropathy family containing both the 11778 and 14484 primary mutations. Am J Med Genet 2001;104:331–338.
  • Howell N, Miller NR, Mackey DA, et al. Lightning strikes twice: Leber hereditary optic neuropathy families with two pathogenic mtDNA mutations. J Neuroophthalmol 2002;22:262–269.
  • Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve. Am J Ophthalmol 2005;140:517–523.
  • Riordan-Eva P, Harding AE. Leber’s hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations. J Med Genet 1995;32:81–87.
  • Joseph B, Srinivasan A, Soumittra N, et al. RPE65 gene: multiplex PCR and mutation screening in patients from India with retinal degenerative diseases. J Genet 2002;81:19–23.
  • Kirkman MA, Yu-Wai-Man P, Korsten A, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009;132:2317–2326.
  • Torroni A, Petrozzi M, D’Urbano L, et al. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet 1997;60:1107–1121.
  • Howell N, Herrnstadt C, Shults C, Mackey DA. Low penetrance of the 14484 LHON mutation when it arises in a non-haplogroup J mtDNA background. Am J Med Genet A 2003;119A:147–151.
  • Mackey D, Oostra RJ, Rosenberg T, et al. Reply to Hofmann et al. Am J Hum Genet 1998;62:492–495.
  • Kerrison JB. Hereditary optic neuropathies. Ophthalmol Clin North Am 2001;14:99–107.
  • Nikoskelainen EK, Marttila RJ, Huoponen K, et al. Leber’s “plus”: neurological abnormalities in patients with Leber’s hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995;59:160–164.
  • Howell N, Kubacka I, Xu M, McCullough DA. Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. Am J Hum Genet 1991;48:935–942.
  • Meire FM, Van Coster R, Cochaux P, Obermaier-Kusser B, Candaele C, Martin JJ. Neurological disorders in members of families with Leber’s hereditary optic neuropathy (LHON) caused by different mitochondrial mutations. Ophthalmic Genet 1995;16:119–126.
  • De Vries DD, Went LN, Bruyn GW, et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 1996;58:703–711.
  • Tarnopolsky MA, Baker SK, Myint T, Maxner CE, Robitaille J, Robinson BH. Clinical variability in maternally inherited leber hereditary optic neuropathy with the G14459A mutation. Am J Med Genet 2004;124A:372–376.
  • Gropman A, Chen TJ, Perng CL, et al. Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation. Am J Med Genet 2004;124A:377–382.
  • Jun AS, Trounce IA, Brown MD, Shoffner JM, Wallace DC. Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia. Mol Cell Biol 1996;16:771–777.
  • Boghen DR, Glaser JS. Ischemic optic neuropathy. Brain 1975;98:689–708.
  • Miller NR, Newman NJ. Anterior Ischemic Optic Neuropathy. In: Miller NR, Newman NJ, eds. Walsh and Hoyt’s Clinical Neuro-ophthalmology, 5 ed. Philadelphia: Saunders, 2000: 212–226.
  • Miller GR, Smith JL. Ischemic optic neuropathy. Am J Ophthalmol 1966;62:103–115.
  • Swartz NG, Beck RW, Savino PJ, et al. Pain in anterior ischemic optic neuropathy. Journal of Neuro-Ophthalmology 1995;15:9–10.
  • Eagling EM, Sanders MD, Miller SJH. Ischaemic papillopathy. Clinical and fluorescein aniographic review of forty cases. British Journal of Ophthalmology 1974;58:990–1008.
  • Knox DL, Duke JR. Slowly progressive ischemic optic neuropathy. Transactions of the American Academy of Ophthalmology and Otolaryngology 1971;75:1065–1068.
  • Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. 2001;132:734.
  • Kennerdell J, Bruchis A, Chung S, et al. Ischemic optic neuropathy decompression trial—Twenty-four-month update. Archives of Ophthalmolology 2000;118:793–798.
  • Optic nerve decompression surgery for nonarteritic anterior ischemic Optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. 1995;273:625.
  • Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy [see comments]. [Review]. 1993;116:759.
  • Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994;118:766.
  • Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983;96:478–483.
  • Lessell S. Nonarteritic anterior ischemic optic neuropathy: enigma variations [editorial]. Archives of Ophthalmolology 1999;117:386–388.
  • Sasarman F, Antonicka H, Shoubridge EA. The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2. Hum Mol Genet 2008;17:3697–3707.
  • Hayreh SS, Podhajsky P. Visual field defects in anterior ischemic optic neuropathy. Doc. Ophthalmol. Proc. Ser. 1979;19:53–71.
  • Frohman EM, Frohman TC, Zee DS, McColl R, Galetta S. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 2005;4:111–121.
  • Harding AE, Riordan-Eva P, Govan GG. Mitochondrial DNA diseases: genotype and phenotype in Leber’s hereditary optic neuropathy. Muscle Nerve 1995;3:S82–84.
  • Charlmers RM, Harding AE. A case-control study of Leber’s hereditary optic neuropathy. Brain 1996;119 (Pt 5):1481–1486.
  • Kalman B, Lublin FD, Alder H. Mitochondrial DNA mutations in multiple sclerosis. Mult Scler 1995;1:32–36.
  • Mayr-Wohlfart U, Paulus C, Henneberg A, Rodel G. Mitochondrial DNA mutations in multiple sclerosis patients with severe optic involvement. Acta Neurol Scand 1996;94:167–171.
  • Morrissey SP, Borruat FX, Miller DH, et al. Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry 1995;58:70–74.
  • Sartore M, Grasso M, Piccolo G, et al. Leber’s hereditary optic neuropathy (LHON)-related mitochondrial DNA sequence changes in italian patients presenting with sporadic bilateral optic neuritis. Biochem Mol Med 1995;56:45–51.
  • Botelho PJ, Johnson LN, Arnold AC. The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1996;121:450.
  • Beck RW, Hayreh SS. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy [letter]. Eye 2000;14 ( Pt 1):118.
  • Fazzone HE, Kupersmith MJ, Leibmann J. Does topical brimonidine tartrate help NAION? Br J Ophthalmol 2003;87:1193–1194.
  • Guy J. New therapies for optic neuropathies: development in experimental models. Curr Opin Ophthalmol 2000;11:421–429.
  • Ennafaa H, Cabrera VM, Abu-Amero KK, et al. Mitochondrial DNA haplogroup H structure in North Africa. BMC Genet 2009;10:8.
  • Abu-Amero KK, Larruga JM, Cabrera VM, Gonzalez AM. Mitochondrial DNA structure in the Arabian Peninsula. BMC Evol Biol 2008;8:45.
  • Abu-Amero KK, Gonzalez AM, Larruga JM, Bosley TM, Cabrera VM. Eurasian and African mitochondrial DNA influences in the Saudi Arabian population. BMC Evol Biol 2007;7:32.
  • MITOMAP: A Human Mitochondrial Genome Database. http://www.mitomap.org. In, 2009.
  • Chinnery PF, Brown DT, Andrews RM, et al. The mitochondrial ND6 gene is a hot spot for mutations that cause Leber’s hereditary optic neuropathy. Brain 2001;124:209–218.
  • Gropman A, Chen TJ, Perng CL, et al. Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation. Am J Med Genet A 2004;124A:377–382.
  • Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci U S A 1994;91:6206–6210.
  • Tarnopolsky MA, Baker SK, Myint T, Maxner CE, Robitaille J, Robinson BH. Clinical variability in maternally inherited leber hereditary optic neuropathy with the G14459A mutation. Am J Med Genet A 2004;124A:372–376.
  • Fauser S, Luberichs J, Besch D, Leo-Kottler B. Sequence analysis of the complete mitochondrial genome in patients with Leber’s hereditary optic neuropathy lacking the three most common pathogenic DNA mutations. Biochem Biophys Res Commun 2002;295:342–347.
  • Nikoskelainen EK, Huoponen K, Juvonen V, Lamminen T, Nummelin K, Savontaus ML. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 1996;103:504–514.
  • Lamminen T, Huoponen K, Sistonen P, et al. mtDNA haplotype analysis in Finnish families with leber hereditary optic neuroretinopathy. Eur J Hum Genet 1997;5:271–279.
  • Smith JL, Hoyt WF, Susac JO. Ocular fundus in acute Leber optic neuropathy. Arch Ophthalmol 1973;90:349–354.
  • Abu-Amero KK, Bosley TM, Bohlega S, McLean D. Complex I respiratory defect in LHON plus dystonia with no mitochondrial DNA mutation. Br J Ophthalmol 2005;89:1380–1381.
  • Abu-Amero KK, Bosley TM. Mitochondrial abnormalities in patients with LHON-like optic neuropathies. Invest Ophthalmol Vis Sci 2006;47:4211–4220.
  • Dogulu CF, Kansu T, Seyrantepe V, Ozguc M, Topaloglu H, Johns DR. Mitochondrial DNA analysis in the Turkish Leber’s hereditary optic neuropathy population. Eye 2001;15:183–188.
  • Howell N. Leber hereditary optic neuropathy: respiratory chain dysfunction and degeneration of the optic nerve. Vision Res 1998;38:1495–1504.
  • Schapira AH. Mitochondrial disorders: an overview. J Bioenerg Biomembr 1997;29:105–107.
  • Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 1997;29:131–149.
  • Howell N. LHON and other optic nerve atrophies: the mitochondrial connection. Dev Ophthalmol 2003;37:94–108.
  • Barron MJ, Griffiths P, Turnbull DM, Bates D, Nichols P. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br J Ophthalmol 2004;88:286–290.
  • Brown MD, Trounce IA, Jun AS, Allen JC, Wallace DC. Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber’s hereditary optic neuropathy mitochondrial DNA mutation. J Biol Chem 2000;275:39831–39836.
  • Kortuem K, Geiger LK, Levin LA. Differential susceptibility of retinal ganglion cells to reactive oxygen species. Invest Ophthalmol Vis Sci 2000;41:3176–3182.
  • Klivenyi P, Karg E, Rozsa C, et al. alpha-Tocopherol/lipid ratio in blood is decreased in patients with Leber’s hereditary optic neuropathy and asymptomatic carriers of the 11778 mtDNA mutation. J Neurol Neurosurg Psychiatry 2001;70:359–362.
  • Danielson SR, Wong A, Carelli V, Martinuzzi A, Schapira AH, Cortopassi GA. Cells bearing mutations causing Leber’s hereditary optic neuropathy are sensitized to Fas-Induced apoptosis. J Biol Chem 2002;277:5810–5815.
  • Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet 1989;1:637–639.
  • Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol 1999;19:28–33.
  • Newman NJ, Torroni A, Brown MD, Lott MT, Fernandez MM, Wallace DC. Epidemic neuropathy in Cuba not associated with mitochondrial DNA mutations found in Leber’s hereditary optic neuropathy patients. Cuba Neuropathy Field Investigation Team. Am J Ophthalmol 1994;118:158–168.
  • Abu-Amero KK, Bosley TM. Mitochondrial DNA abnormalities in NAION. Br J Ophthalmol 2007;91:1561.
  • Bosley TM, Constantinescu CS, Tench CR, Abu-Amero KK. Mitochondrial changes in leukocytes of patients with optic neuritis. Mol Vis 2007;13:1516–1528.
  • Moraes CT, Atencio DP, Oca-Cossio J, Diaz F. Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations. J Mol Diagn 2003;5:197–208.
  • Chinnery PF, Howell N, Andrews RM, Turnbull DM. Mitochondrial DNA analysis: polymorphisms and pathogenicity. J Med Genet 1999;36:505–510.
  • DiMauro S. Lessons from mitochondrial DNA mutations. Semin Cell Dev Biol 2001;12:397–405.
  • DiMauro S, Andreu AL. Mutations in mtDNA: Are we scraping the bottom of the barrel? Brain Pathol 2000;10:431–441.
  • DiMauro S, Schon EA. Mitochondrial DNA mutations in human disease. Am J Med Genet 2001;106:18–26.
  • Santos C, Sierra B, Alvarez L, et al. Frequency and pattern of heteroplasmy in the control region of human mitochondrial DNA. J Mol Evol 2008;67:191–200.
  • Black GC, Morten K, Laborde A, Poulton J. Leber’s hereditary optic neuropathy: heteroplasmy is likely to be significant in the expression of LHON in families with the 3460 ND1 mutation. Br J Ophthalmol 1996;80:915–917.
  • Kochanski A. Pathogenic mutations and non-pathogenic DNA polymorphisms in the most common neurodegenerative disorders. Folia Neuropathol 2007;45:164–169.
  • Mroczek-Tonska K, Kisiel B, Piechota J, Bartnik E. Leber hereditary optic neuropathy—a disease with a known molecular basis but a mysterious mechanism of pathology. J Appl Genet 2003;44:529–538.
  • Mitchell AL, Elson JL, Howell N, Taylor RW, Turnbull DM. Sequence variation in mitochondrial complex I genes: mutation or polymorphism? J Med Genet 2006;43:175–179.
  • Wong LJ. Pathogenic mitochondrial DNA mutations in protein-coding genes. Muscle Nerve 2007;36:279–293.
  • Yen MY, Chen CS, Wang AG, Wei YH. Increase of mitochondrial DNA in blood cells of patients with Leber’s hereditary optic neuropathy with 11778 mutation. Br J Ophthalmol 2002;86:1027–1030.
  • Chiappini F, Teicher E, Saffroy R, et al. Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients. Lab Invest 2004;84:908–914.
  • Abu-Amero KK, Bosley TM. Reassessment of the pathologic significance of the 9438 mitochondrial DNA mutation associated with LHON. Ophthalmic Genet 2007;28:229–230.
  • Abu-Amero KK, Morales J, Osman MN, Bosley TM. Nuclear and mitochondrial analysis of patients with primary angle-closure glaucoma. Invest Ophthalmol Vis Sci 2007;48:5591–5596.
  • Abu-Amero KK, Ozand PT, Al-Dhalaan H. Novel mitochondrial DNA transversion mutation in transfer ribonucleic acid for leucine 2 (CUN) in a patient with the clinical features of MELAS. J Child Neurol 2006;21:971–972.
  • Sunyaev S, Ramensky V, Koch I, Lathe W, 3rd, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001;10:591–597.
  • Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res 2002;12:436–446.
  • Hoyt CS, Good WV. The many challenges of childhood blindness. Br J Ophthalmol 2001;85:1145–1146.
  • Bosley TM, Brodsky MC, Glasier CM, Abu-Amero KK. Sporadic bilateral optic neuropathy in children: the role of mitochondrial abnormalities. Invest Ophthalmol Vis Sci 2008;49:5250–5256.
  • Barboni P, Savini G, Valentino ML, et al. Leber’s Hereditary Optic Neuropathy with Childhood Onset. Invest Ophthalmol Vis Sci 2006;47:5303–5309.
  • Brodsky MC, Glasier CM. Optic nerve hypoplasia. Clinical significance of associated central nervous system abnormalities on magnetic resonance imaging. Arch Ophthalmol 1993;111:66–74.
  • Abu-Amero KK, Morales J, Bosley TM. Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2006;47:2533–2541.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.